secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001145197-22-000059
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet Q3 revenue $340.8M (+24% YoY) beat guidance; Omnipod 5 drives 42% US growth
--------------------------------------------------------------------------------

- Revenue $340.8M, +23.7% YoY (+28.5% constant currency), above guidance of 17-20% constant currency.
- US Omnipod revenue $238.1M (+42.4% YoY) on record new customer starts; International Omnipod $88.0M (-5.5%, +8.9% CC).
- Adjusted EPS $0.45; GAAP net loss $(0.08)/share includes $36.8M charge for voluntary Omnipod DASH PDM correction.
- Adjusted gross margin 66.1% (excl. PDM charge); GAAP gross margin 55.3%, down 1,320 bps.
- Received CE Mark for Omnipod 5; expanded US indication to age 2; new basal-only pod for type 2 diabetes planned for 510(k).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000114519722000059/0001145197-22-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000114519722000059/podd-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001145197-22-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer